Literature DB >> 26465063

Quo vadis nanomedicine?

Matthias Barz1, Robert Luxenhofer2, Michael Schillmeier3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26465063     DOI： 10.2217/nnm.15.156

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN： 1743-5889            Impact factor:   5.307


× No keyword cloud information.
  2 in total

Review 1.  Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization.

Authors:  Susan Hua; Maria B C de Matos; Josbert M Metselaar; Gert Storm
Journal:  Front Pharmacol       Date:  2018-07-17       Impact factor: 5.810

Review 2.  Liposomal Nanosystems in Rheumatoid Arthritis.

Authors:  Margarida Ferreira-Silva; Catarina Faria-Silva; Pedro Viana Baptista; Eduarda Fernandes; Alexandra Ramos Fernandes; Maria Luísa Corvo
Journal:  Pharmaceutics       Date:  2021-03-27       Impact factor: 6.321
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.